Sutent price (correction)
Executive Summary
Based on the wholesale acquisition cost of Sutent (sunitinib), which is $6,412.50 for a 30 count bottle of 50 mg capsules, the product's average monthly cost is $4,275. This prices Sutent at a slight discount to Bayer/Onyx' Nexavar (sorafenib) which carries a WAC of $4,333 for a one-month supply. In a previous story on the approval of Sutent, "The Pink Sheet" incorrectly identified the price of the product and incorrectly referred to the average wholesale price of Nexavar as the price to patients (1"The Pink Sheet" Jan. 30, 2006, p. 4)...
You may also be interested in...
Pfizer Oncologic Sutent Will Have Dosing, Slight Price Advantage Over Nexavar
Pfizer's newly approved oncologic Sutent will have a dosing advantage and will be priced at a slight discount compared to Bayer/Onyx' Nexavar
Sanofi Paid $14.6bn In Rebates In 2020; Net Prices Were Down
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
Can Vir/GSK’s COVID-19 Antibody Prove Its Worth In Early Disease?
Other antibody treatments have shown efficacy in early-stage disease after faltering in hospitalized patients.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: